Comparative analysis of anxiety-depressive spectrum disorders in patients with rheumatic diseases

TA Lisitsyna, DY Veltishchev, OF Seravina… - Terapevticheskii …, 2018 - ter-arkhiv.ru
Research objective-comparative analysis of incidence and structure of anxiety-depressive
spectrum disorders (ADD) in patients with various rheumatic diseases (RD). Materials and …

Anticancer activity of methyl-substituted oxaliplatin analogs

U Jungwirth, DN Xanthos, J Gojo, AK Bytzek… - Molecular …, 2012 - ASPET
Oxaliplatin is successfully used in systemic cancer therapy. However, resistance
development and severe adverse effects are limiting factors for curative cancer treatment …

{(1R,2R,4R)-4-Methyl-1,2-cyclohexanediamine}oxalatoplatinum(II): A Novel Enantiomerically Pure Oxaliplatin Derivative Showing Improved Anticancer Activity in …

SA Abramkin, U Jungwirth, SM Valiahdi… - Journal of medicinal …, 2010 - ACS Publications
Novel derivatives of the clinically established anticancer drug oxaliplatin were synthesized.
Cytotoxicity of the compounds was studied in six human cancer cell lines by means of the …

Depression and severity of articular destruction in patients with rheumatoid arthritis

AA Abramkin, TA Lisitsyna, DY Veltishchev… - Terapevticheskii …, 2020 - ter-arkhiv.ru
Aim. To assess the influence of anxiety and depressive disorders on joint destruction in
patients with rheumatoid arthritis (RA). Materials and methods. 128 RA-patients were …

Molecular and crystal structure of tris-(2-hydroxyethyl) ammonium 4-chlorophenoxy acetate

SV Loginov, AM Abramkin, VB Rybakov… - Crystallography …, 2012 - Springer
Abstract Tris-(2-hydroxyethyl) ammonium 4-chlorophenoxy acetate has been synthesized
and characterized by 1 H NMR spectra. The molecular structure of this compound has been …

[HTML][HTML] Effects of synthetic disease-modifying antirheumatic drugs, biological agents, and psychopharmacotherapy on the mental disorders in patients with …

AA Abramkin, TA Lisitsyna, DY Veltishchev… - Научно …, 2017 - cyberleninka.ru
Mental disorders (MDs) of the anxiety-depressive spectrum (ADS) and cognitive impairment
(CI) are characteristic of the majority of patients with rheumatoid arthritis (RA); however, the …

Synthesis and structure of N-(2-silatranylethyl)imidazoles

VD Sheludyakov, NE Kuz'mina, AM Abramkin… - Russian Journal of …, 2011 - Springer
Organosilicon imidazole derivatives containing a 2-silatranylethyl [N (CH 2 CH 2 O) 3 Si (CH
2) 2] group on the nitrogen atom were synthesized, and their steric and electronic structures …

Methyl-substituted trans-1, 2-cyclohexanediamines as new ligands for oxaliplatin-type complexes

L Habala, C Dworak, AA Nazarov, CG Hartinger… - Tetrahedron, 2008 - Elsevier
Three different pathways for the synthesis of substituted trans-(±)-1, 2-cyclohexanediamines
as new ligands for oxaliplatin-type compounds are presented. The different synthetic routes …

Chronic pain and depression in patients with rheumatoid arthritis: results of five-year follow-up

TA Lisitsyna, AA Abramkin, DY Veltishchev… - Terapevticheskii …, 2019 - ter-arkhiv.ru
The aim of the study was to analyze the factors affecting chronic pain in patients with
rheumatoid arthritis (RA). Materials and methods. 128 patients with reliable diagnosis of RA …

Treatment of patients with osteoporosis in modern clinical practice: adherence to therapy

…, AY Feklistov, NV Demin, A Abramkin - … and Bone Diseases, 2015 - osteo-endojournals.ru
Aim. To assess the patients compliance to treatment of osteoporosis (OP). Materials and
methods. Poll study of random sample of 1565 patients (86% women and 14% men) with OP …